All Vaccinology articles – Page 9
-
NewsDNA vaccine against zika performs well in tests on mice
A Zika vaccine developed in Brazil and tested on mice has been found to be efficacious, inducing an immune response against the virus and protecting the animals appropriately.
-
NewsImproved oral cholera vaccine achieves WHO PQ
EuBiologics and the International Vaccine Institute (IVI) announced that Euvichol-S, an improved oral cholera vaccine (OCV) developed jointly by EuBiologics and IVI, has achieved World Health Organization prequalification.
-
NewsVaccine breakthrough means no more chasing strains
Scientists have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised.
-
NewsChatGPT could help reduce vaccine hesitancy and provide helpful advice on STIs
A pilot study shows the potential for using AI chatbots to assist public health campaigns in reducing vaccine hesitancy as well as providing helpful advice on STIs and access to care.
-
NewsResearchers develop more broadly protective coronavirus vaccine
Researchers have developed a new vaccine that offers broad protection against not only SARS-CoV-2 variants, but also other bat sarbecoviruses.
-
NewsCase report shows mpox breakthrough infection in man who had received both vaccine doses
New research details the case of a man who had received two doses of the monkey pox vaccine in Autumn, 2022 yet experienced a ‘breakthrough’ mpox infection in January 2024.
-
NewsStudy shows Mpox (monkeypox) antibodies wane within a year of vaccination
New research shows that the antibodies produced by Modified Vaccinia virus Ankara - Bavarian Nordic (MVA-BN) vaccination against mpox wane significantly within a year of receiving the vaccination.
-
NewsSignificant decline of neutralising antibodies to monkeypox virus during the first month after vaccination
New research shows that even in men who receive two doses of mpox vaccine intradermally, their level of antibodies to the virus falls to low or zero within the first few months if they have not received a previous smallpox vaccine.
-
NewsTB vaccine may enable elimination of the disease in cattle by reducing its spread
Vaccination not only reduces the severity of TB in infected cattle, but reduces its spread in dairy herds by 89%, research finds.
-
NewsInsights from patient who cleared hepatitis C could lead to vaccine
By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide with case numbers increasing every year.
-
NewsNew vaccine against a highly fatal tropical disease – and potential bioterror weapon – demonstrates efficacy in animal studies
In a mouse study, researchers tested a vaccine against the bacterium that causes melioidosis and found it was highly protective against the disease, which is endemic in many tropical areas.
-
NewsNew study provides insights into COVID-19 vaccine uptake among children and young people
COVID-19 vaccine uptake among children and young people was low across all four UK nations, compared to other age groups, according to the first research study to look at data from all four UK nations.
-
NewsCommunity-based cohort study to track short- and long-term effects of multiple respiratory viruses
Scientists are initiating a critical two-year prospective epidemiologic study in the spring of 2024 to track acute respiratory infections across the United States.
-
NewsAddressing both flu and COVID-19 through a single, multitasking injection
A study found a protein triggered the influx of acquired T cells and the proliferation of innate-like T cells in the lungs, which mounted a swift and comprehensive defense against a broad spectrum of pathogens.
-
NewsPowerful new AI can predict people’s attitudes to vaccines
A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics and personal judgments such as aversion to risk or loss.
-
NewsStudy maps main genes involved in immune response to infection by dengue virus
Researchers compared data for the immune response induced by natural infection and vaccines. They identified the key factors in the development of long-lasting immunity.
-
NewsIVI starts technology transfer to Biological E. Limited to manufacture oral cholera vaccine for India and global markets
The International Vaccine Institute (IVI) has announced that it has commenced a technology transfer of simplified Oral Cholera Vaccine (OCV-S) to Biological E. Limited (BE), a leading India-based vaccines and pharmaceutical company.
-
NewsNew nasal vaccine platform helps clear COVID-19 infections in an animal model
Researchers demonstrate proof-of-principle of a protein-based platform, called SpyCage, that could eventually help to prevent infection and transmission of respiratory viruses, like SARS-CoV-2.
-
NewsStudy indicates need for typhoid conjugate vaccines in endemic countries
A new study calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.
-
NewsStudy reveals low COVID-19 transmission rate from mothers to newborns
COVID-19 vaccination reduces risks of severe outcomes in pregnant women, who show fewer harmful effects from the Omicron variant, a study shows. It also reveals that COVID-19 transmission from mothers to their newborns is low.
